Progyny (PGNY) | Stock Overview & Key Data
Progyny Performance Comparison
Stock Range
Today's Range
Low: $22.35
High: $23.33
on August 21, 2025
52 Week Range
Low: $13.39
High: $26.76
on November 15, 2024
on February 28, 2025
All-Time High: $68.32 on November 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.0B
EPS
0.59
P/E Ratio (TTM)
38.54
Forward P/E
29.92
P/B Ratio
3.77
PEG Ratio
3.47
Div. Yield
N/A
ROE
10.94%
Beta
1.325
Debt to Equity
5.56
Financial Highlights
Profitability
Gross Margin
23.72%
Operating Margin
7.32%
Profit Margin
4.28%
Returns and Earnings
Return on Assets (TTM)
6.57%
Return on Equity (TTM)
10.94%
EBITDA
$80.8M
Net Income (TTM)
$53.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$14.56
Quarterly Revenue Growth (YoY)
9.50%
Quarterly Earnings Growth (YoY)
3.80%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Progyny PGNY | 1.96B Small-cap | 2.57% | 0.83% | 9.16% | -0.30% | 30.46% | 6.10% | -44.49% | -19.10% |
| UnitedHealth UNH | 279.39B Mega-cap | 11.74% | 7.52% | 0.12% | -34.96% | -39.87% | -48.10% | -42.68% | -3.51% |
| CVS Health CVS | 87.01B Large-cap | 7.04% | 15.88% | 15.01% | 12.52% | 61.53% | 21.58% | -28.61% | 13.00% |
| Clover Health CLOV | 1.34B Small-cap | 1.56% | -16.08% | -25.85% | -40.68% | -16.61% | -21.86% | -8.42% | -74.98% |
| Cigna CI | 79.24B Large-cap | 3.65% | 2.09% | -5.09% | 0.38% | 9.64% | -14.98% | 5.64% | 66.13% |
| Elevance Health ELV | 70.84B Large-cap | 4.80% | 11.99% | -22.62% | -19.61% | -15.37% | -43.29% | -35.96% | 11.66% |
Ownership & Short Interest
Insider Ownership
7.60%
Institutional Ownership
104.36%
Shares Short
8M
Short Ratio
7.47
Short % of Shares Outstanding
12.48%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Progyny Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Progyny would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PGNY's 52-week high and low?
- In the last 52 weeks, Progyny reached a high of $26.76 (on February 28, 2025) and a low of $13.39 (on November 15, 2024).
- What is the market cap and P/E ratio for PGNY?
- Curious about Progyny's size and valuation? Its market capitalization stands at 1.96B. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.54, and the forward P/E (looking ahead) is 29.92.
- Does PGNY pay dividends? If so, what's the yield?
- As for dividends, Progyny isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Progyny's main competitors or similar companies to consider before investing?
When looking at Progyny, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH279.39B Healthcare Healthcare Plans -48.10% -42.68% CVS Health
CVS87.01B Healthcare Healthcare Plans 21.58% -28.61% Clover Health
CLOV1.34B Healthcare Healthcare Plans -21.86% -8.42% Cigna
CI79.24B Healthcare Healthcare Plans -14.98% 5.64% Elevance Health
ELV70.84B Healthcare Healthcare Plans -43.29% -35.96% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Progyny Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Progyny's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 10.94%, the Debt to Equity ratio from the most recent quarter is 5.56, and its Gross Profit Margin stands at 23.72%.
- What is the recent revenue and earnings growth for PGNY?
- Looking at Progyny's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.50%, and quarterly earnings saw a YoY growth of 3.80%.
- How much of PGNY stock is held by insiders and institutions?
- Wondering who owns Progyny stock? Company insiders (like executives and directors) hold about 7.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 104.36%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.